Phase 3, Adolescent Large Scale Safety Study

Update Il y a 4 ans
Reference: EUCTR2009-015198-11

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the safety profile of rLP2086 vaccine, as measured by adverse events (AEs), during the 6-month vaccination period and 6-month postdose 3 follow-up.


Inclusion criteria

  • bacterial meningitis